Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Cepeginterferon alfa-2B

Generic Name: Cepeginterferon alfa-2B

Drug Type: Biotech

CAS Number: 1192706-52-7

Unique Ingredient Identifier: 6J022WTC4Y

Overview

Cepeginterferon alfa-2B is under investigation in clinical trial NCT01889433 (An Open-label Comparative Efficacy and Safety Study of Algeron (Cepeginterferon Alfa-2b) in Treatment-naive Patients With Chronic Hepatitis C).

Background

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

An Open-label Randomized Multicenter Phase III Clinical Study Comparing Safety and Efficacy of Algeron (Cepeginterferon Alfa-2b) and and PegIntron (Peginterferon Alfa-2b) in Combination With Ribavirin as Combined Treatment of Chronic Hepatitis C in Human Immunodeficiency Virus-1 Infected Patients

Phase 3

Completed

Posted: 2014/04/03

Sponsor:Biocad

ID:NCT02103439

An Open-label Comparative Efficacy and Safety Study of Algeron (Cepeginterferon Alfa-2b) in Treatment-naive Patients With Chronic Hepatitis C

Phase 3

Completed

Posted: 2013/06/28

Sponsor:Biocad

ID:NCT01889433

Algeron (Cepeginterferon Alfa-2b) Compared With PegIntron (Peginterferon Alfa-2b) for Treatment of Chronic Hepatitis C

Phase 2

Completed

Posted: 2012/12/04

Sponsor:Biocad

ID:NCT01740089

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy